Finance

Lists
Why is 002019 up 2,06%?
Dive Deeper
002019:SHE
Yifan Pharmaceutical Co Ltd
9,42 CNY
+2,06%
(+0,19) 1D
16 ოქტ, 12:26:42 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002019...
Open
9,35 CNY
High
9,48 CNY
Low
9,30 CNY
Mkt. cap
11,47 მლრდ.
Avg. vol.
7,58 მლნ.
Volume
4,61 მლნ.
Dividend
1,06%
Quarterly dividend
0,02 CNY
Ex-dividend date
29 მაი. 2026
P/E ratio
37,70
52-wk high
14,73 CNY
52-wk low
9,07 CNY
EPS
0,25 CNY
Shares outstanding
1,22 მლრდ.
No. of employees
4 ათ.
Open
9,35 CNY
High
9,48 CNY
Low
9,30 CNY
Mkt. cap
11,47 მლრდ.
Avg. vol.
7,58 მლნ.
Volume
4,61 მლნ.
Dividend
1,06%
Quarterly dividend
0,02 CNY
Ex-dividend date
29 მაი. 2026
P/E ratio
37,70
52-wk high
14,73 CNY
52-wk low
9,07 CNY
EPS
0,25 CNY
Shares outstanding
1,22 მლრდ.
No. of employees
4 ათ.
News stories
From web sources and news partners
marketscreener.com
marketscreener.com
·
14 წუთის წინ
Epiroc trades today on Nasdaq Stockholm ex-dividend by 1.90 kronor per share
marketscreener.com
marketscreener.com
·
23 წუთის წინ
S&P 500 index rose slightly after Stockholm exchange close Thursday
Investor's Business Daily
Investor's Business Daily
·
1 საათის წინ
Futures Mixed; Anthropic Value, Tesla Roadster In Focus
AP News
AP News
·
10 საათის წინ
Average long-term US mortgage rate holds at 7.4%, remaining at highest level in nearly 3 years
About Yifan Pharmaceutical Co Ltd
CEO-
Employees4,18 ათ.
Founded1994
Headquarters-
SectorPharmaceutical industry
Websiteyifanyy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,29 მლრდ.
1,21 მლრდ.
1,26 მლრდ.
1,21 მლრდ.
Cost of goods sold
683,41 მლნ.
709,78 მლნ.
680,09 მლნ.
660,52 მლნ.
Cost of revenue
683,41 მლნ.
709,78 მლნ.
680,09 მლნ.
660,52 მლნ.
Research and development expenses
73,24 მლნ.
99,51 მლნ.
54,37 მლნ.
84,82 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
394,37 მლნ.
380,61 მლნ.
352,15 მლნ.
322,47 მლნ.
Operating expense
414,49 მლნ.
557,61 მლნ.
426,93 მლნ.
417,72 მლნ.
Total operating expenses
1,10 მლრდ.
1,27 მლრდ.
1,11 მლრდ.
1,08 მლრდ.
Operating income
189,70 მლნ.
-57,15 მლნ.
148,49 მლნ.
133,82 მლნ.
Other non operating income
4,02 მლნ.
-9,75 მლნ.
-9,25 მლნ.
3,87 მლნ.
EBT including unusual items
90,49 მლნ.
-11,11 მლნ.
120,86 მლნ.
108,42 მლნ.
EBT excluding unusual items
171,87 მლნ.
-75,15 მლნ.
130,13 მლნ.
108,62 მლნ.
Income tax expense
14,39 მლნ.
-24,31 მლნ.
25,15 მლნ.
16,74 მლნ.
Effective tax rate
15,91%
218,84%
20,81%
15,44%
Other operating expenses
-60,21 მლნ.
83,25 მლნ.
11,12 მლნ.
9,35 მლნ.
Net income
84,14 მლნ.
14,23 მლნ.
106,83 მლნ.
98,20 მლნ.
Net profit margin
6,53%
1,18%
8,51%
8,10%
Earnings per share
-
-
-
-
Interest and investment income
2,44 მლნ.
4,17 მლნ.
2,64 მლნ.
2,83 მლნ.
Interest expense
-16,54 მლნ.
-10,67 მლნ.
-11,75 მლნ.
-11,28 მლნ.
Net interest expenses
-14,10 მლნ.
-6,51 მლნ.
-9,11 მლნ.
-8,46 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
268,85 მლნ.
25,45 მლნ.
231,09 მლნ.
220,93 მლნ.
Gain or loss from assets sale
3,86 მლნ.
-12,70 მლნ.
-
1,53 მლნ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები